Jill Reckless is the co-founder and CEO at RxCelerate. She offers an insightful strategic vision and provides extensive leadership within the business. She is involved in the development of novel anti-inflammatory drugs both within the University as a Senior Research Associate and as part of Funxional Therapeutics as Head of Biology. Previously, she worked with Total Scientific, a Contract Research Organisation which specialises in providing biomarker-related services to the pharmaceutical, diagnostic and academic communities.

Having completed her PhD at the National Heart and Lung Institute in London, Jill was an academic at the University of Cambridge until December 2011.